Bio­gen, Sam­sung Bioepis look to carve up a block­buster Roche fran­chise with deep dis­count biosim­i­lar

Bio­gen and their biosim­i­lar part­ners at Sam­sung Bioepis are rolling out their copy­cat ver­sion of Roche’s an­ti-VEGF block­buster Lu­cen­tis to­day, 8 months af­ter it was …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.